Doximity earnings release, August 6, 2026
Doximity Announces Fiscal 2027 First Quarter Financial Results
Total revenues of $156.6 million, up 7% year-over-year
Net income of $24.3 million, margin of 16%
Adjusted EBITDA of $74.8 million, margin of 48%
SAN FRANCISCO, Calif., August 6, 2026
-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 first quarter ended June 30, 2026.
“We're proud that our clinical AI assistant, Doximity Ask, was the top-performing U.S.-based model in the NOHARM benchmark while we delivered another quarter of record engagement,” said Jeff Tangney, co-founder and CEO of Doximity. "In Q1 we had accelerated revenue growth along with workflow active prescriber growth of more than 30% year-over-year and AI Search query growth of over 25% quarter-over-quarter.”
Fiscal 2027 First Quarter Financial Highlights
All comparisons, unless otherwise noted, are to the three months ended June 30, 2025.
• Revenue:
Revenue of $156.6 million, versus $145.9 million, an increase of 7% year-over-year.
• Net income and non-GAAP net income:
Net income of $24.3 million, versus $53.3 million, representing a margin of 15.5%, versus 36.5%. Non-GAAP net income of $55.0 million, versus $71.9 million, representing a margin of 35.1%, versus 49.2%.
• Adjusted EBITDA:
Adjusted EBITDA of $74.8 million, versus $79.8 million, a decrease of 6% year-over-year, representing adjusted EBITDA margins of 47.7%, versus 54.7%.
• Diluted net income per share and non-GAAP diluted net income per share:
Diluted net income per share was $0.13, versus $0.27, while non-GAAP diluted net income per share was $0.29, versus $0.36.
• Operating cash flow and free cash flow
: Operating cash flow of $42.0 million, versus $62.1 million, a decrease of 32% year-over-year, and free cash flow of $39.6 million, versus $60.1 million, a decrease of 34% year-over-year.
Financial Outlook
Doximity is providing guidance for its fiscal second quarter ending September 30, 2026 as follows:
• Revenue between $170 million and $171 million.
• Adjusted EBITDA between $80.5 million and $81.5 million.
Doximity is updating guidance for its fiscal year ending March 31, 2027 as follows:
• Revenue between $671 million and $681 million.
• Adjusted EBITDA between $309 million and $329 million.
For more detailed financial commentary, please refer to the “Modeling Considerations” appendix in our prepared remarks.¹
Conference Call Information
Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The recorded webcast will be available on the Company’s Investor Relations page shortly after the call.
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. With new AI-powered clinical reference and search capabilities, Doximity also helps doctors access trusted, peer-reviewed information and medical literature. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.
Financial statements
Income Statement
Three Months Ended June 30, — (unaudited)
| Three Months Ended June 30, – 2026 | 2025 | ||
|---|---|---|---|
| Revenue | 156,618 | 145,913 | |
| Cost of revenue(1) | 23,692 | 15,793 | |
| Gross profit | 132,926 | 130,120 | |
| Operating expenses(1): | Research and development | 38,477 | 26,799 |
| Operating expenses(1): | Sales and marketing | 45,049 | 36,365 |
| Operating expenses(1): | General and administrative | 15,756 | 12,439 |
| Operating expenses(1): | Total operating expenses | 99,282 | 75,603 |
| Operating expenses(1): | Income from operations | 33,644 | 54,517 |
| Operating expenses(1): | Other income, net | 6,719 | 9,630 |
| Operating expenses(1): | Income before income taxes | 40,363 | 64,147 |
| Operating expenses(1): | Provision for income taxes | 16,048 | 10,827 |
| Operating expenses(1): | Net income | 24,315 | 53,320 |
| Net income per share attributable to Class A and Class B common stockholders: | Basic | 0.13 | 0.28 |
| Net income per share attributable to Class A and Class B common stockholders: | Diluted | 0.13 | 0.27 |
| Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders: | Basic | 182,569 | 187,984 |
| Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders: | Diluted | 191,169 | 201,158 |
Income Statement
Three Months Ended June 30, — (1) Costs and expenses include stock-based compensation expense as follows (in thousands):
| Three Months Ended June 30, – 2026 | 2025 | |
|---|---|---|
| Cost of revenue | 3,192 | 2,980 |
| Research and development | 15,559 | 6,649 |
| Sales and marketing | 12,425 | 7,710 |
| General and administrative | 5,576 | 4,526 |
| Total stock-based compensation expense | 36,752 | 21,865 |
Income Statement
Three Months Ended June 30, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)
| Three Months Ended June 30, – 2026 – (unaudited) | 2025 – (unaudited) | ||
|---|---|---|---|
| Net income | 24,315 | 53,320 | |
| Adjusted to exclude the following: | Acquisition and other related expenses | 428 | |
| Adjusted to exclude the following: | Stock-based compensation | 36,752 | 21,865 |
| Adjusted to exclude the following: | Depreciation and amortization | 4,287 | 2,794 |
| Adjusted to exclude the following: | Provision for income taxes | 16,048 | 10,827 |
| Adjusted to exclude the following: | Change in fair value of contingent earn-out consideration liability | 90 | 168 |
| Adjusted to exclude the following: | Other income, net | -6,719 | -9,630 |
| Adjusted to exclude the following: | Adjusted EBITDA | 74,773 | 79,772 |
| Adjusted to exclude the following: | Revenue | 156,618 | 145,913 |
| Adjusted to exclude the following: | Net income margin | 15.5 | 36.5 |
| Adjusted to exclude the following: | Adjusted EBITDA margin | 47.7 | 54.7 |
Income Statement
Three Months Ended June 30, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)
| Three Months Ended June 30, – 2026 – (unaudited) | 2025 – (unaudited) | ||
|---|---|---|---|
| GAAP cost of revenue | 23,692 | 15,793 | |
| Adjusted to exclude the following: | Stock-based compensation | -3,192 | -2,980 |
| Adjusted to exclude the following: | Amortization of acquired intangibles | -935 | |
| Adjusted to exclude the following: | Non-GAAP cost of revenue | 19,565 | 12,813 |
| Adjusted to exclude the following: | GAAP gross profit | 132,926 | 130,120 |
| Adjusted to exclude the following: | Stock-based compensation | 3,192 | 2,980 |
| Adjusted to exclude the following: | Amortization of acquired intangibles | 935 | |
| Adjusted to exclude the following: | Non-GAAP gross profit | 137,053 | 133,100 |
| Adjusted to exclude the following: | GAAP gross margin | 84.9 | 89.2% |
| Adjusted to exclude the following: | Non-GAAP gross margin | 87.5 | 91.2% |
| Adjusted to exclude the following: | GAAP research and development expense | 38,477 | 26,799 |
| Adjusted to exclude the following: | Stock-based compensation | -15,559 | -6,649 |
| Adjusted to exclude the following: | Non-GAAP research and development expense | 22,918 | 20,150 |
| Adjusted to exclude the following: | GAAP sales and marketing expense | 45,049 | 36,365 |
| Adjusted to exclude the following: | Stock-based compensation | -12,425 | -7,710 |
| Adjusted to exclude the following: | Amortization of acquired intangibles | -1,005 | -1,002 |
| Adjusted to exclude the following: | Change in fair value of contingent earn-out consideration liability | -90 | -168 |
| Adjusted to exclude the following: | Non-GAAP sales and marketing expense | 31,529 | 27,485 |
| Adjusted to exclude the following: | GAAP general and administrative expense | 15,756 | 12,439 |
| Adjusted to exclude the following: | Acquisition and other related expenses | -428 | |
| Adjusted to exclude the following: | Stock-based compensation | -5,576 | -4,526 |
| Adjusted to exclude the following: | Non-GAAP general and administrative expense | 10,180 | 7,485 |
| Adjusted to exclude the following: | GAAP operating expense | 99,282 | 75,603 |
| Adjusted to exclude the following: | Acquisition and other related expenses | -428 | |
| Adjusted to exclude the following: | Stock-based compensation | -33,560 | -18,885 |
| Adjusted to exclude the following: | Amortization of acquired intangibles | -1,005 | -1,002 |
| Adjusted to exclude the following: | Change in fair value of contingent earn-out consideration liability | -90 | -168 |
| Adjusted to exclude the following: | Non-GAAP operating expense | 64,627 | 55,120 |
Income Statement
Three Months Ended June 30, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)
| Three Months Ended June 30, – 2026 – (unaudited) | 2025 – (unaudited) | ||
|---|---|---|---|
| GAAP operating income | 33,644 | 54,517 | |
| Adjusted to exclude the following: | Acquisition and other related expenses | 428 | |
| Adjusted to exclude the following: | Stock-based compensation | 36,752 | 21,865 |
Balance Sheet
June 30, 2026 — (unaudited)
| June 30, 2026 | March 31, 2026 | ||
|---|---|---|---|
| Current assets: | Cash and cash equivalents | 273,604 | 219,178 |
| Current assets: | Marketable securities | 414,185 | 529,423 |
| Current assets: | Accounts receivable, net | 177,575 | 144,783 |
| Current assets: | Prepaid expenses and other current assets | 48,614 | 50,880 |
| Current assets: | Total current assets | 913,978 | 944,264 |
| Current assets: | Property and equipment, net | 19,243 | 18,080 |
| Current assets: | Deferred income tax assets | 23,839 | 31,984 |
| Current assets: | Operating lease right-of-use assets | 6,752 | 7,140 |
| Current assets: | Intangible assets, net | 33,385 | 35,325 |
| Current assets: | Goodwill | 84,973 | 84,973 |
| Current assets: | Other assets | 1,675 | 1,921 |
| Current assets: | Total assets | 1,083,845 | 1,123,687 |
| Current liabilities: | Accounts payable | 6,494 | 4,009 |
| Current liabilities: | Accrued expenses and other current liabilities | 32,666 | 42,804 |
| Current liabilities: | Deferred revenue, current | 109,061 | 106,050 |
| Current liabilities: | Operating lease liabilities, current | 2,142 | 2,110 |
| Current liabilities: | Total current liabilities | 150,363 | 154,973 |
| Current liabilities: | Deferred revenue, non-current | 37 | 400 |
| Current liabilities: | Operating lease liabilities, non-current | 7,531 | 8,075 |
| Current liabilities: | Other liabilities, non-current | 9,844 | 9,402 |
| Current liabilities: | Total liabilities | 167,775 | 172,850 |
| Stockholders' Equity | Common stock | 180 | 183 |
| Stockholders' Equity | Additional paid-in capital | 1,035,282 | 1,001,688 |
| Stockholders' Equity | Accumulated other comprehensive income (loss) | -348 | 28 |
| Stockholders' Equity | Accumulated deficit | -119,044 | -51,062 |
| Stockholders' Equity | Total stockholders’ equity | 916,070 | 950,837 |
| Stockholders' Equity | Total liabilities and stockholders’ equity | 1,083,845 | 1,123,687 |
Cash Flow
Three Months Ended June 30, — (unaudited)
| Three Months Ended June 30, – 2026 | 2025 | ||
|---|---|---|---|
| Cash flows from operating activities | Net income | 24,315 | 53,320 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Depreciation and amortization | 4,287 | 2,794 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Stock-based compensation, net of amounts capitalized | 36,752 | 21,865 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Non-cash lease expense | 387 | 450 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Accretion of discount on marketable securities, net | -568 | -2,488 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Amortization of deferred contract costs | 4,300 | 3,896 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Other | -338 | -408 |
| Changes in operating assets and liabilities: | Accounts receivable | -33,334 | -13,381 |
| Changes in operating assets and liabilities: | Prepaid expenses and other assets | 9,125 | -4,234 |
| Changes in operating assets and liabilities: | Deferred contract costs | -2,642 | -1,965 |
| Changes in operating assets and liabilities: | Accounts payable, accrued expenses and other liabilities | -2,433 | -165 |
| Changes in operating assets and liabilities: | Deferred revenue | 2,648 | 2,973 |
| Changes in operating assets and liabilities: | Operating lease liabilities | -512 | -556 |
| Changes in operating assets and liabilities: | Net cash provided by operating activities | 41,987 | 62,101 |
| Cash flows from investing activities | Purchases of property and equipment | -62 | |
| Cash flows from investing activities | Internal-use software development costs | -2,322 | -1,966 |
| Cash flows from investing activities | Purchases of marketable securities | -14,746 | -139,934 |
| Cash flows from investing activities | Maturities of marketable securities | 126,071 | 144,579 |
| Cash flows from investing activities | Sales of marketable securities | 4,049 | |
| Cash flows from investing activities | Net cash provided by investing activities | 112,990 | 2,679 |
| Cash flows from financing activities | Proceeds from issuance of common stock upon exercise of stock options and common stock warrants | 3,080 | 2,398 |
| Cash flows from financing activities | Taxes paid related to net share settlement of equity awards | -6,974 | -11,927 |
| Cash flows from financing activities | Repurchase of common stock | -91,633 | -122,355 |
Cash Flow
Three Months Ended June 30, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)
| Three Months Ended June 30, – 2026 – (unaudited) | 2025 – (unaudited) | ||
|---|---|---|---|
| Net cash provided by operating activities | 41,987 | 62,101 | |
| Purchases of property and equipment | -62 | ||
| Internal-use software development costs | -2,322 | -1,966 | |
| Free cash flow | 39,603 | 60,135 | |
| Other cash flow components: | Net cash provided by investing activities | 112,990 | 2,679 |
| Other cash flow components: | Net cash used in financing activities | -100,551 | -137,133 |
Full release
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Forward-looking statements are all statements other than statements of historical fact, and specifically include statements regarding guidance and future business and financial results. These statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Investor Relations Contact:
Perry Gold ir@doximity.com
Media Contact:
Richard George pr@doximity.com²